Skip to the page

Data / Form D filings / GOLDEN SUNRISE NUTRACEUTICAL INC

GOLDEN SUNRISE NUTRACEUTICAL INC: Form D filings

GOLDEN SUNRISE NUTRACEUTICAL INC, a pharmaceuticals company in Porterville, CA, filed 2 Form D notices with the SEC between 2017 and 2025. The latest, on June 20, 2025, reports an offering of no set size with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
219 NORTH E STREET, Porterville, CA, 93257
Phone
(559) 781-0658
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1705521

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 20, 2025New noticeIndefinite$00Yet to occursec.gov
May 10, 2017New noticeIndefinite$00Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Martin F. LoefflerExecutive Officer
Rachel M. AyalaDirector
Huu S. TieuDirector

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Jun 16, 2025 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what GOLDEN SUNRISE NUTRACEUTICAL INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.